Azenta, Inc. (NASDAQ:AZTA) Shares Bought by Picton Mahoney Asset Management

Picton Mahoney Asset Management grew its holdings in Azenta, Inc. (NASDAQ:AZTA) by 305.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 706 shares of the company’s stock after purchasing an additional 532 shares during the quarter. Picton Mahoney Asset Management’s holdings in Azenta were worth $35,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Ballentine Partners LLC raised its position in shares of Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company’s stock valued at $1,017,000 after buying an additional 404 shares during the period. Glenmede Trust Co. NA raised its position in shares of Azenta by 6.3% during the 3rd quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company’s stock valued at $551,000 after buying an additional 679 shares during the period. KBC Group NV raised its position in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after buying an additional 698 shares during the period. Oregon Public Employees Retirement Fund raised its position in Azenta by 7.0% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company’s stock valued at $535,000 after purchasing an additional 702 shares during the period. Finally, Victory Capital Management Inc. raised its position in Azenta by 4.0% in the third quarter. Victory Capital Management Inc. now owns 27,281 shares of the company’s stock valued at $1,321,000 after purchasing an additional 1,061 shares during the period. 99.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Evercore ISI boosted their target price on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th. Stephens reissued an “overweight” rating and issued a $60.00 target price on shares of Azenta in a research report on Thursday, January 2nd. TD Cowen raised Azenta to a “hold” rating in a research report on Thursday, February 27th. Finally, Needham & Company LLC boosted their target price on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research report on Thursday, February 6th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $58.75.

Azenta Stock Up 0.7 %

NASDAQ:AZTA opened at $36.80 on Monday. The company has a fifty day simple moving average of $48.16 and a two-hundred day simple moving average of $47.03. The company has a market cap of $1.68 billion, a price-to-earnings ratio of -12.35 and a beta of 1.52. Azenta, Inc. has a 52 week low of $35.90 and a 52 week high of $63.58.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, analysts expect that Azenta, Inc. will post 0.53 EPS for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.